Raludotatug Biosimilar - Research Grade

Human

CDH6ï؟½

5mg/ml

IgG1 - kappa

CHO Cells

https://www.imgt.org/mAb-DB/

ICH3002

P55285

Blue ice

CDH6 (cadherin-6) is a cell-adhesion protein overexpressed in renal and ovarian cancers and exploited for targeted-payload research. This recombinant human IgG1 kappa antibody is an unconjugated, non-therapeutic analog of raludotatug, produced in CHO cells against human CDH6. For research use only, it is formulated to low endotoxin for in vivo compatibility and supplied in scalable milligram (mg) to gram (g) quantities for bulk, high-throughput laboratories. It is well suited to antigen-expression profiling, functional binding and internalization assays, in vivo tumor models, and antibody-drug conjugate development. The format is optimized for reproducible results across high-volume study designs.

This monoclonal antibody was purified using Protein A

Sterile, preservative-free, solution in PBS. BSA and Azide free.

This biosimilar is stable when stored at 2-8°C. For longer term storage (> 3 months) it is recommended to store this antibody at -20°C or -70°C.

Functional Assays

This biosimilar is for research use only (RUO): it is not for diagnostic or therapeutic procedures and cannot be purchased by patients.

Products are for research use only. Not for use in diagnostic or therapeutic procedures.

3-4 weeks